FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. Lovega LLC dba Pink Pony Peptides

    FDA warned Pink Pony Peptides that its GLP-2 TZ, GLP-3 RT and Bacteriostatic Water are unapproved new drugs sold online.

    High risk
  2. 123Herbals

    FDA warned 123Herbals that SILINTAN and other herbal products are unapproved drugs, and SILINTAN contains hidden meloxicam.

    High risk
  3. USApeptide.com

    FDA warns Germany-based USApeptide.com that it sells unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers online.

    High risk
  4. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  5. US Chem Labs

    FDA warned US Chem Labs that it sells unapproved and misbranded Semaglutide, Tirzepatide, and Thymalin drugs online.

    High risk
  6. www.ivermectin4covid.com

    FDA warned website ivermectin4covid.com for selling unapproved, misbranded ivermectin drugs claiming COVID-19 use.

    High risk
  7. pharmahealthonline.com

    FDA warned pharmahealthonline.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.

    High risk